Showing 2061-2070 of 8204 results for "".
How Can I Reduce Irritation from Face Masks?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/how-can-i-reduce-irritation-from-face-masks/19824/Friction from masks can initiate an inflammatory response. Dr. Friedman explains how to reduce and prevent the inflammation with facial moisturizers and other tools.COVID-19 Impact: Navigating Clinical Research
https://practicaldermatology.com/series/dermatology-dispatches/covid-19-impact-navigating-clinical-research/19771/Conducting clinical research studies is challenging as the majority of Americans are under stay-at-home orders for the forseeable future due to the COVID-19 pandemic, says Todd E. Schlesinger, MD. He suggests trialists do their best to say in contact with clinical research organizations, sponsors, aSystemic Treatment for Skin Cancers
https://practicaldermatology.com/topics/skin-cancer-photoprotection/systemic-treatment-for-skin-cancers/19662/Anisha B. Patel, MD discusses the latest advances in systemic treatment for melanoma with host Joshua Zeichner, MD. She reviews how treatments work, the most common cutaneous reactions patients experience, and the dermatologist's role in managing those reactions and reassuring patients that these reHot Topic: Medical Photography, EHRs, and Augmented Reality Technology
https://practicaldermatology.com/topics/practice-management/hot-topic-medical-photography-ehrs-and-augmented-reality-technology-/19568/Todd E. Schlesinger, MD and Joel L. Cohen discuss advances in the pipeline in terms of photo storage, search functionality in electronic medical records, and the emergence of augmented reality technology in patient and physician education.Treating Moderate to Severe Psoriasis: Weighing the Treatment Options
https://practicaldermatology.com/topics/psoriasis/-treating-moderate-to-severe-psoriasis-weighing-the-treatment-options/18375/In part 2 of her interview with DermTube Journal Club host Joshua Zeichner, MD, Erin Boh, MD reviews new biologics that provide patients with moderate to severe psoriasis improved treatment options. She discusses their efficacy and safety and offers tips for finding the right one for each patient baCosmetic Controversies
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/cosmetic-controversies--fwjagege/18202/With the variety of devices on the market, aesthetic physicians may not even realize all the options available. They can reduce chin fat and cellulite, treat melasma, and even help patients build muscle. Jeanine Downie, MD discusses options.How to Use Email Effectively to Build Client Loyalty
https://practicaldermatology.com/topics/practice-management/email-loyalty/18218/Using email effectively can help you encourage client loyalty as well as client satisfaction. This Ekwa Marketing video explains how you can do this to optimize client experience and motivate clients to return.FDA Approvals, Acne Insights, EPI Gets Cloderm
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-fda-approvals-acne-insights-epi-gets-cloderm/18230/In a flurry of approvals, FDA gives the nod to Almirall's Seysara (sarecycline), Ortho Dermatologics' Bryhali (halobetasol propionate, 0.01%) Lotion, Paratek Pharmaceuticals' Nuzyra (omadacycline), and Regeneron's Libtayo (cemiplimab). Research shows top earners across various fields in the US mayMeeting Recap: Aesthetic Extenders Symposium 2018
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/meeting-recap-aesthetic-extenders-symposium-2018/18234/Faculty and industry partners discuss the highlights of the Aesthetic Extenders Symposium. From novel uses of toxins to skincare and injections techniques, AES provided a range of updates. AES 2019 will be held in Miami, FL.Altreno's Approval, Psoriasis Insights
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-altreno-s-approval-psoriasis-insights--nxhineya/18236/Ortho Dermatologics' Altreno lotion is now approved for the topical treatment of acne vulgaris in patients ages 9 and up. Altreno, containing tretinoin 0.05%, will be available during the fourth quarter of this year. The FDA has accepted Ortho Dermatologics' resubmitted New Drug Application for Duob